The store will not work correctly when cookies are disabled.
2-((6-(4-fluoro-3-methylphenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)methyl)oxazole
ID: ALA4526512
PubChem CID: 124176103
Max Phase: Preclinical
Molecular Formula: C18H14FN3O
Molecular Weight: 307.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cnc3ccn(Cc4ncco4)c3c2)ccc1F
Standard InChI: InChI=1S/C18H14FN3O/c1-12-8-13(2-3-15(12)19)14-9-17-16(21-10-14)4-6-22(17)11-18-20-5-7-23-18/h2-10H,11H2,1H3
Standard InChI Key: HKJPMNDKQPARAT-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
4.7862 -16.7648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7850 -17.5843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4931 -17.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4913 -16.3559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1999 -16.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2047 -17.5843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9891 -17.8341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4691 -17.1653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9813 -16.5023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0770 -17.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3712 -17.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6637 -17.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6626 -18.8072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3749 -19.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0796 -18.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3772 -20.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9551 -19.2161 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.2462 -18.6099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0465 -18.7751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3824 -19.5170 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1946 -19.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3598 -18.6265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6497 -18.2221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
13 17 1 0
7 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.33 | Molecular Weight (Monoisotopic): 307.1121 | AlogP: 4.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 43.85 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.27 | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.57 | Np Likeness Score: -1.58 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |